The real impact of drug price legislation on biopharmaceutical R&D

2 October 2019 - As outcry around drug prices rages, arguments continue to surface that limiting corporate revenues via price controls ...

Read more →

Progressing the long-term plan for stem cell research

2 October 2019 - This is the next step in the $150 million Stem Cell Therapies Mission, helping world-class Australian researchers ...

Read more →

Clinical trials to combat reproductive cancers

9 September 2019 - The Australian Government is investing up to $15 million in targeted clinical trials to improve treatments and ...

Read more →

$32 million available to support vital translational health

5 September 2019 - The Australian Government is opening the door for Australian researchers through a $32 million investment that will ...

Read more →

Chinese stealing health and medical research data: report

21 August 2019 - The global healthcare sector, including Australia, faces increasing cyber threats and malicious activity from Chinese groups, ...

Read more →

Azar's plan to tie U.S. drug prices to foreign ones will impact investments in R&D

21 June 2019 - Americans, be they Republicans or Democrats, are outraged by the rising cost of prescription drugs.  ...

Read more →

Pharma groups combine to promote drug discovery with AI

5 June 2019 - Blockchain system allows companies to share data without revealing commercial secrets. ...

Read more →

A new study sparks a war of words over the drug industry’s commitment to research

14 May 2019 - The pharmaceutical industry spends about $1 in $5 of its revenues on research and development. ...

Read more →

Medicines Australia welcomes ALP R&D investment pledge

8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...

Read more →

$65 million to unlock the potential of personalised medicine through genomics

26 March 2019 - The Australian Government will provide over $65 million in competitive research grants to Australia’s best and brightest ...

Read more →

On the use of list prices in drug pricing research

14 March 2019 - In the limitations section of this article, we discussed in detail that list prices do not capture ...

Read more →

Citizens ask - scientists answer: the IQWiG sets four new topics for HTA reports

23 January 2019 - Citizens, patients and medical experts: selection of topics with a sense of proportion ...

Read more →

China pharma must swallow that jagged little pill called R&D as government slashes profit margins of generic drugs

19 January 2019 - New policy environment demanding cheaper drugs adds pressure to innovate. ...

Read more →

Canadian R&D-to-sales ratio for brand-name drug companies less than half of 10% commitment

3 December 2018 - USMCA concessions latest hit to Canadian prescription drug costs. ...

Read more →

Request for proposals for PHARMAC and HRC research partnership 2019

8 October 2018 - PHARMAC and the Health Research Council of New Zealand request research proposals. ...

Read more →